The rise of bispecifics and other next-generation antibody formats brings new promise for patients—along with unique CMC challenges that can delay progress and add cost. Success requires not just solving technical issues, but understanding how design choices, process development, and quality considerations connect across development stages.
Drawing on Lonza’s experience supporting next-generation biologics from early development to first-in-human manufacturing, this on-demand webinar shares real-world case studies that reveal how strategic CMC planning, cross-functional collaboration, and effective CDMO partnerships can help programs move forward with confidence.
What you’ll learn
- How to recognize and avoid common pitfalls in next-generation biologics development
- Practical strategies to reduce risk and accelerate timelines—from cell line development to IND-enabling GMP manufacturing
- Lessons from real-world case studies guiding next-generation molecules to first-in-human milestones
Complete the form to watch the webinar on demand.
